Neal Fowler

Overview

Mr. Fowler joined Liquidia in 2008 after seven successful years at Johnson & Johnson (J&J). While at J&J Neal served as President of Centocor Inc. a multi billion dollar subsidiary focused on development and commercialization of industry leading biomedicines used in the treatment of chronic inflammatory diseases. At Centocor Mr. Fowler prepared the company for the launch of two potential blockbuster products and continued the company's legacy of double digit growth for their flagship product REMICADE (infliximab). Prior to Centocor Mr. Fowler was president of Ortho McNeil Neurologics Inc. and vice president of the central nervous system franchise at Ortho McNeil Pharmaceuticals. Mr. Fowler joined J&J after a successful 13 year career at Eli Lilly and Company where he held a variety of sales marketing and business development roles with increasing responsibilities in both the pharmaceutical and medical divisions. Mr. Fowler is a native of Raleigh NC and received a Bachelor of Science degree in Pharmacy and Masters of Business Administration from the University of North Carolina at Chapel Hill (UNC CH).